Congestive Heart Failure Clinical Trial
Official title:
Hemodynamic Assessment Throughout Diuretic Treatment in Acute Decompensated Heart Failure
NCT number | NCT03535909 |
Other study ID # | RS-2018-S01 |
Secondary ID | |
Status | Completed |
Phase | |
First received | |
Last updated | |
Start date | June 9, 2018 |
Est. completion date | July 31, 2018 |
Verified date | March 2019 |
Source | Rodin Scientific LLC |
Contact | n/a |
Is FDA regulated | No |
Health authority | |
Study type | Observational |
This study will assess the ability of a novel optical measurement system to determine changes in the hemodynamic status of heart failure patients admitted to the hospital with a primary diagnosis of acute decompensated heart failure. Patients will be measured with both the novel measurement system and reference devices that are FDA-cleared for hemodynamic measurements. The measurements from the novel system will be compared to reference variables describing hemodynamic and congestive status, including stroke volume, central venous pressure, and serum levels of NT-proBNP.
Status | Completed |
Enrollment | 5 |
Est. completion date | July 31, 2018 |
Est. primary completion date | June 24, 2018 |
Accepts healthy volunteers | No |
Gender | All |
Age group | 18 Years to 80 Years |
Eligibility |
Inclusion Criteria: - Age = 18 years - Admission to the hospital with a primary diagnosis of acute decompensated heart failure - Treated with or planned treatment with intravenous diuretics - Volume overload, as indicated by at least one of the following clinical signs: - Peripheral edema - Pulmonary edema on physical examination - Pleural effusions on chest x-ray - Jugular venous distension on physical examination - CVP > 10 cmH2O - Presence of third heart sound - Able to understand study procedures, agree to participate in the study program and voluntarily provide written informed consent Exclusion Criteria: - Inability or refusal to sign the Subject Informed Consent - Age > 80 years - Body mass index (BMI) > 40 - Planned mechanical ventilation during hospitalization - Presence of left ventricular assist device (LVAD) - Dialysis - Pregnancy. All women of childbearing potential must have a negative pregnancy test before enrollment. - Parenteral diuretic or other medical treatment for ADHF already administered for more than 12 hours prior to enrollment - Skin damage to the optical sampling sites (fingers and dorsal hand), to include tattoos, scars, cuts, or burns extending over more than 30% of the visible tissue - Compromised superficial hand veins or proximal venous stenosis - Intravenous lines connected to both arms - Inability to stand with support, if needed, for 4 minutes - Inability to place hand in the venous imaging enclosure due to forearm, elbow, or shoulder injuries, or other physical constraints - Inability to wear fingertip or ring sensors on three fingers (of either hand) due to missing fingers, injured fingers, or other physical constraints - Persons in police custody or prisoners - Major medical or psychiatric condition that would interfere with the ability to complete the study |
Country | Name | City | State |
---|---|---|---|
Croatia | University Hospital of Split | Split | |
United States | New Mexico Heart Institute | Albuquerque | New Mexico |
Lead Sponsor | Collaborator |
---|---|
Rodin Scientific LLC | University of Split, School of Medicine |
United States, Croatia,
Type | Measure | Description | Time frame | Safety issue |
---|---|---|---|---|
Primary | Accuracy of Estimated Changes in Stroke Volume | Comparison of Stroke Volume Measurement (units of ml) from the optical measurement system with paired Stroke Volume Measurement (ml) from the reference device. Accuracy will be measured in percentage error and Bland-Altman limits of agreement. | Retrospective up to 6 months after study completion | |
Secondary | Accuracy of Central Venous Pressure Measurement | Comparison of Central Venous Pressure Measurement (units of cmH2O) from the optical measurement system with paired Central Venous Pressure Measurement (cmH2O) from the reference device. Accuracy will be measured in percentage error and Bland-Altman limits of agreement. | Retrospective up to 6 months after study completion |
Status | Clinical Trial | Phase | |
---|---|---|---|
Terminated |
NCT04115735 -
His Bundle Recording From Subclavian Vein
|
||
Recruiting |
NCT05562037 -
Stepped Care vs Center-based Cardiopulmonary Rehabilitation for Older Frail Adults Living in Rural MA
|
N/A | |
Completed |
NCT05563701 -
Evaluation of the LVivo Image Quality Scoring (IQS)
|
||
Recruiting |
NCT05865184 -
Evaluation of Home-based Sensor System to Detect Health Decompensation in Elderly Patients With History of CHF or COPD
|
||
Completed |
NCT04037436 -
Functional Exercise and Nutrition Education Program for Older Adults
|
N/A | |
Recruiting |
NCT04703842 -
Modulation of SERCA2a of Intra-myocytic Calcium Trafficking in Heart Failure With Reduced Ejection Fraction
|
Phase 1/Phase 2 | |
Terminated |
NCT05594940 -
Heart Failure Monitoring With a Portable Ultrasound Device With Artificial Intelligence Assisted Tools: A Multi-Phase Observational Feasibility Study
|
||
Recruiting |
NCT04982081 -
Treating Congestive HF With hiPSC-CMs Through Endocardial Injection
|
Phase 1 | |
Completed |
NCT04394754 -
Evaluating Efficacy of Digital Health Technology in the Treatment of Congestive Heart Failure
|
N/A | |
Active, not recruiting |
NCT01385176 -
Neural Cardiac Therapy for Heart Failure Study (NECTAR-HF)
|
N/A | |
Not yet recruiting |
NCT05516290 -
Evaluating Clinical Trial Experiences of Individuals With Congestive Heart Failure
|
||
Completed |
NCT02885636 -
Inhaled Beta-adrenergic Agonists to Treat Pulmonary Vascular Disease in Heart Failure With Preserved EF (BEAT HFpEF): A Randomized Controlled Trial
|
Phase 3 | |
Terminated |
NCT02788656 -
Pulmonary Artery Pressure Reduction With ENTresto (Sacubitril/Valsartan)
|
Phase 4 | |
Completed |
NCT02252757 -
Assess Measurements of Wireless Cardiac Output Device
|
N/A | |
Terminated |
NCT02205411 -
Clinical Trial to Evaluate the the ReliantHeart HeartAssist 5® VAD System in Patients Awaiting Heart Transplantation
|
N/A | |
Completed |
NCT01362855 -
Advance Care Planning Evaluation in Hospitalized Elderly Patients
|
||
Completed |
NCT01476995 -
Prognostic Indicators as Provided by the EPIC ClearView
|
N/A | |
Withdrawn |
NCT00346177 -
Stem Cell Study for Patients With Heart Failure
|
Phase 2 | |
Active, not recruiting |
NCT01058837 -
SCD-HeFT 10 Year Follow-up
|
N/A | |
Completed |
NCT00957541 -
Evaluation of a Diagnostic Feature in a Cardiac Resynchronization Therapy (CRT) Device
|
Phase 2 |